Impact of fluid intake in the prevention of urinary system diseases: A brief review

Current Opinion in Nephrology and Hypertension

Volumn 22, Issue SUPPL.1, 2013, Pages

  Lotan, Yair ^a   Daudon, Michel ^b   Bruyère, Franck ^f   Talaska, Glenn ^g   Strippoli, Giovanni ^c   Johnson, Richard J ^d   Tack, Ivan ^e  

^a UNIVERSITY OF TEXAS SOUTHWESTERN MEDICAL CENTER   (United States)

^b HÔPITAL TENON   (France)

^c UNIVERSITY OF BARI   (Italy)

^d UNIVERSITY OF COLORADO   (United States)

^e TOULOUSE UNIVERSITY HOSPITAL   (France)

^f UNIVERSITY HOSPITAL OF TOURS   (France)

^g UNIVERSITY OF CINCINNATI COLLEGE OF MEDICINE   (United States)

Author keywords

bladder cancer; chronic kidney disease; fluid intake; urinary tract infection; urolithiasis

Indexed keywords

ASYMPTOMATIC BACTERIURIA; BACTERIAL CLEARANCE; BLADDER CANCER; CALCIUM OXALATE STONE; CANCER RISK; CHRONIC KIDNEY DISEASE; COST EFFECTIVENESS ANALYSIS; ENVIRONMENTAL FACTOR; ESCHERICHIA COLI; FLUID INTAKE; GLOMERULUS FILTRATION RATE; HUMAN; INFECTION RISK; PATHOGENESIS; PATHOPHYSIOLOGY; PRIORITY JOURNAL; REVIEW; RISK ASSESSMENT; STAPHYLOCOCCUS SAPROPHYTICUS; URINARY TRACT DISEASE; URINARY TRACT INFECTION; URINE VOLUME; UROLITHIASIS;

DRINKING; EVIDENCE-BASED MEDICINE; HUMANS; RENAL INSUFFICIENCY, CHRONIC; RISK FACTORS; URINARY BLADDER NEOPLASMS; URINARY TRACT INFECTIONS; UROLITHIASIS; UROLOGIC DISEASES; WATER-ELECTROLYTE BALANCE;

EID: 84878892183     PISSN: 10624821     EISSN: 14736543     Source Type: Journal    
DOI: 10.1097/MNH.0b013e328360a268     Document Type: Review

References (91)

1. Deen PM, Verdijk MA, Knoers NV, et al. Requirement of human renal water channel aquaporin-2 for vasopressin-dependent concentration of urine. Science 1994; 264:92-95. (Pubitemid 24144492)
2. Popkin BM, D'Anci KE, Rosenberg IH. Water, hydration, and health. Nutr Rev 2010; 68:439-458.
3. Verbalis J. How does the brain sense osmolality? J Am Soc Nephrol 2007; 18:3056-3059. (Pubitemid 350223965)
4. European Food Safety Authority (EFSA) Panel on Dietetic Products, Nutrition, and Allergies. Scientific opinion on dietary reference values for water. EFSA J 2010; 8:1459.
5. D-A-CH (Deutsche Gesellschaft fü r Ernährung-O sterreichische Gesellschaft fü r Ernährung-Schweizerische Gesellschaft fü r Ernä hrungsforschung-Schweizerische Vereinigung fü r Ernä hrung), 2008. Referenzwerte fü r die Nä hrstoffzufuhr. Umschau Braus Verlag, Frankfurt am Main.
6. Eckford SD, Keane DP, Lamond E, et al. Hydration monitoring in the prevention of recurrent idiopathic urinary tract infections in premenopausal women. Br J Urol 1995; 76:90-93.
7. Nygaard I, Linder M. Thirst at work: an occupational hazard? Int Urogynecol J Pelvic Floor Dysfunct 1997; 8:340-343.
8. Frank M, De Vries A, Tikva P. Prevention of urolithiasis. Education to adequate fluid intake in a new town situated in the Judean Desert Mountains. Arch Environment Health 1966; 13:625-630.
9. Borghi L, Meschi T, Amato F, et al. Urinary volume, water and recurrences in idiopathic calcium nephrolithiasis: a 5-year randomized prospective study. J Urol 1996; 155:839-843. (Pubitemid 26052660)
10. Strippoli GF, Craig JC, Rochtchina E, et al. Fluid and nutrient intake and risk of chronic kidney disease. Nephrology (Carlton) 2011; 16:326-334.
11. Clark WF, Sontrop JM, Macnab JJ, et al. Urine volume and change in estimated GFR in a community-based cohort study. Clin J Am Soc Nephrol 2001; 6:2634-2641.
12. Michaud DS, Spiegelman D, Clinton SK, et al. Fluid intake and the risk of bladder cancer in men. N Engl J Med 1999; 340:1390-1397. (Pubitemid 29205402)
13. Zeegers MP, Kellen E, Buntinx F, van den Brandt PA. The association between smoking, beverage consumption, diet and bladder cancer: a systematic literature review. World J Urol 2004; 21:392-401.
14. Jiang X, Yuan JM, Skipper PL, et al. Environmental tobacco smoke and bladder cancer risk in never smokers of Los Angeles County. Cancer Res 2007; 67:7540-7545. (Pubitemid 47206585)
15. Pinduli I, Spivacow R, del Valle E, et al. Prevalence of urolithiasis in the autonomous city of Buenos Aires. Argentina Urol Res 2006; 34:8-11. (Pubitemid 43234708)
16. Ramello A, Vitale C, Marangella M. Epidemiology of nephrolithiasis. J Nephrol 2000; 13 (Suppl 3):S45-S50.
17. Scales CD Jr, Curtis LH, Norris RD, et al. Changing gender prevalence of stone disease. J Urol 2007; 177:979-982. (Pubitemid 46216342)
18. Soucie JM, Coates R, McClellan W, et al. Relation between geographic variability in kidney stones prevalence and risk factors for stones. Am J Epidemiology 1996; 143:487-495. (Pubitemid 26085079)
19. Coe FL, Evan AP, Worcester EM, Lingeman JE. Three pathways for human kidney stone formation. Urol Res 2010; 38:147-160.
20. Tiselius HG. Aspects on estimation of the risk of calcium oxalate crystallization in urine. Urol Int 1991; 47:255-259.
21. Taylor EN, Curhan GC. Fructose consumption and the risk of kidney stones. Kidney Int 2008; 73:207-212.
22. Taylor EN, Stampfer MJ, Curhan GC. Dietary factors and the risk of incident kidney stones in men: new insights after 14 years of follow-up. J Am Soc Nephrol 2004; 15:3225-3232. (Pubitemid 39578855)
23. Pearle MS, Lotan Y. Urinary lithiasis: etiology, epidemiology and pathogenesis. In: Wein J, Kavoussi LR, Novick AW, et al., editors. Campbell-Walsh Urology, 10th ed Philadelphia, PA: Saunders; 2012. pp. 1257-1286.
24. Sakhaee K. Recent advances in the pathophysiology of nephrolithiasis. Kidney Int 2009; 75:585-595.
25. Sorensen MD, Kahn AJ, Reiner AP, et al. Impact of nutritional factors on incident kidney stone formation: a report from the WHI OS. J Urol 2012; 187:1645-1649.
26. Daudon M, Lacour B, Jungers P. High prevalence of uric acid calculi in diabetic stone formers. Nephrol Dial Transplant 2005; 20:468-469. (Pubitemid 40276917)
27. Daudon M, Hennequin C, Boujelben G, et al. Serial crystalluria determination and the risk of recurrence in calcium stone formers. Kidney Int 2005; 67:1934-1943. (Pubitemid 40577729)
28. Evans K, Costabile RA. Time to development of symptomatic urinary calculi in a high risk environment. J Urol 2005; 173:858-861. (Pubitemid 40239355)
29. Chen Y-K, Lin H-C, Chen C-S, Yeh S-D. Seasonal variations in urinary calculi attacks and their association with climate: a population based study. J Urol 2008; 179:564-569.
30. Sakhaee K, Nigam S, Snell P, et al. Assessment of the pathogenetic role of physical exercise in renal stone formation. J Clin Endocrinol Metab 1987; 65:974-979. (Pubitemid 17162648)
31. Curhan GC, Willett WC, Rimm EB, et al. Prospective study of beverage use and the risk of kidney stones. Am J Epidemiol 1996; 143:240-247. (Pubitemid 26032629)
32. Curhan GC, Willett WC, Speizer FE, Stampfer MJ. Beverage use and risk for kidney stones in women. Ann Intern Med 1998; 128:534-540. (Pubitemid 28177660)
33. Borghi L, Meschi T, Schianchi T, et al. Urine volume: stone risk factor and preventive measure. Nephron 1999; 81 (Suppl 1):31-37. (Pubitemid 29015465)
34. Lotan Y, Buendia Jiménez I, Lenoir-Wijnkoop I, et al. Increased water intake as a prevention strategy for recurrent urolithiasis: major impact of compliance on cost-effectiveness. J Urol 2013; 189:935-939; doi: 10.1016/j.juro.2012. 08.254.
35. Mulvey MA, Schilling JD, Martinez JJ, Hultgren SJ. Bad bugs and beleaguered bladders: interplay between uropathogenic Escherichia coli and innate host defences. PNAS 2000; 97:8829-8835. (Pubitemid 30626633)
36. Rahn DD. Urinary tract infections: contemporary management. Urol Nurs 2008; 28:333-341.
37. Ronald AR, Nicolle LE, Stamm E, et al. Urinary tract infection in adults: research priorities and strategies. Int J Antimicrob Agents 2001; 17:343-348. (Pubitemid 32288753)
38. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002; 113 (Suppl 1A):5S-13S. (Pubitemid 34756640)
39. Hooton TM, Scholes D, Stapleton AE, et al. A prospective study of asymptomatic bacteriuria in sexually active young women. N Engl J Med 2000; 343:992-997.
40. Foxman B. The epidemiology of urinary tract infection. Nat Rev Urol 2010; 7:653-660.
41. August SL, De Rosa MJ. Evaluation of the prevalence of urinary tract infection in rural Panamanian women. PLoS One 2012; 7:e47752.
42. Nicolle LE, Bradley S, Colgan R, et al. Infectious Diseases Society of America guidelines for the diagnosis and treatment of asymptomatic bacteriuria in adults. Clin Infect Dis 2005; 40:643-654. (Pubitemid 40381336)
43. Beetz R. Mild dehydration: a risk factor of urinary tract infection? Eur J Clin Nutr 2003; 57 (Suppl 2):S52-S58. (Pubitemid 38159629)
44. Scholes D, Hooton TM, Roberts PL, et al. Risk factors for recurrent urinary tract infection in young women. J Infect Dis 2000; 182:1177-1182.
45. Remis RS, Gurwith MJ, Gurwith D, et al. Risk factors for urinary tract infection. Am J Epidemiol 1987; 126:685-694. (Pubitemid 17142240)
46. Su S-B, Wang J-N, Lu C-W, et al. Prevalence of urinary tract infections and associated factors among pregnant workers in the electronics industry. Int Urogynecol J 2009; 20:939-945.
47. Nielsen AF, Walter S. Epidemiology of infrequent voiding and associated symptoms. Scand J Urol Nephrol Suppl 1994; 157:49-53.
48. Omli R, Skotnes LH, Mykletun A, et al. Residual urine as a risk factor for lower urinary tract infection: a 1-year follow-up study in nursing homes. J Am Geriatr Soc 2008; 56:871-874. (Pubitemid 351652385)
49. Stern JA, Hsieh YC, Schaeffer AJ. Residual urine in an elderly female population: novel implications for oral estrogen replacement and impact on recurrent urinary tract infection. J Urol 2004; 171 (2 Pt 1):768-770. (Pubitemid 38090479)
50. Stamm WE, Raz R. Factors contributing to susceptibility of postmenopausal women to recurrent urinary tract infections. Clin Infect Dis 1999; 28:723-725. (Pubitemid 29169404)
51. Cicmanec JF, Shank RA, Evans AT. Overnight concentration of urine. Natural defense mechanism against urinary tract infection. Urology 1985; 26:157-159.
52. United States Renal Data System (USRDS). 2012 Annual Data Report. www.usrds.org/adr.aspx. [Accessed 15 January 2013]
53. Centers for Disease Control and Prevention (CDC). National Chronic Kidney Disease Fact Sheet 2010. www.cdc.gov/diabetes/pubs/factsheets/kidney. htm. [Accessed 15 January 2013]
54. Roderick P, Roth M, Mindell J. Prevalence of chronic kidney disease in England: findings from the 2009 Health Survey for England. J Epidemiol Commun Health 2011; 65 (Suppl 2):A12.
55. Courser WG, Remuzzi WG, Mendis S, Tonelli M. The contribution of chronic kidney disease to the global burden of major noncommunicable diseases. Kidney Int 2011; 80:1258-1270.
56. Lameire N, Van Biesen W. Epidemiology of peritoneal dialysis: a story of believers and nonbelievers. Nat Rev Nephrol 2010; 6:75-82.
57. Xue JL, Ma JZ, Louis TA, Collins AJ. Forecast of the number of patients with end-stage renal disease in the United States to the year. J Am Soc Nephrol 2001; 12:2753-2758. (Pubitemid 33115423)
58. Schlondorff DO. Overview of factors contributing to the pathophysiology of progressive renal disease. Kidney Int 2008; 74:860-866.
59. Wang X, Wu Y, Ward CJ, et al. Vasopressin directly regulates cyst growth in polycystic kidney disease. J Am Soc Nephrol 2008; 19:102-108.
60. Torres VE, Bankir L, Grantham JJ. A case for water in the treatment of polycystic kidney disease. Clin J Am Soc Nephrol 2009; 4:1140-1150.
61. Torres VE. Vasopressin in chronic kidney disease: an elephant in the room? Kidney Int 2009; 76:925-928.
62. Bolignano D, Zoccali C. Vasopressin beyond water: implications for renal diseases. Curr Opin Nephrol Hypertens 2010; 19:499-504.
63. Hebert LA, Greene T, Levey A, et al. High urine volume and low urine osmolality are risk factors for faster progression of renal disease. Am J Kidney Dis 2003; 41:962-971. (Pubitemid 36532130)
64. Jemal A, Siegel R, Xu J, Ward E. Cancer statistics. CA Cancer J Clin 2010; 60:277-300.
65. Ferlay J, Parkin DM, Steliarova-Foucher E. Estimates of cancer incidence and mortality in Europe in 2008. Eur J Cancer 2010; 46:765-781; doi: 10.1016/j.ejca.2009.12.014.
66. Botteman MF, Pashos CL, Redaelli A, et al. The health economics of bladder cancer: a comprehensive review of the published literature. Pharmacoeconomics 2003; 21:1315-1330. (Pubitemid 38041357)
67. Silverman DT, Hartge P, Morrison AS, Devesa SS. Epidemiology of bladder cancer. Hematol Oncol Clin North Am 1992; 6:1-30.
68. Dipple A. DNA adducts of chemical carcinogens. Carcinogenesis 1995; 16:437-441.
69. Zeegers MP, Goldbohm RA, van den Brandt PA. A prospective study on active and environmental tobacco smoking and bladder cancer risk (The Netherlands). Cancer Causes Control 2002; 13:83-90. (Pubitemid 34163954)
70. Bjerregaard BK, Raaschou-Nielsen O, Sørensen M, et al. Tobacco smoke and bladder cancer-in the European Prospective Investigation into Cancer and Nutrition. Int J Cancer 2006; 119:2412-2416. (Pubitemid 44546965)
71. Jiang X, Castelao JE, Groshen S, et al. Water intake and bladder cancer risk in Los Angeles County. Int J Cancer 2008; 123:1649-1656.
72. Talaska G, al-Juburi AZ, Kadlubar FF. Smoking related carcinogen-DNA adducts in biopsy samples of human urinary bladder: identification of N-(deoxyguanosin-8-yl)-4-aminobiphenyl as a major adduct. Proc Natl Acad Sci USA 1991; 88:5350-5354. (Pubitemid 21914742)
73. Zeegers MP, Tan FE, Dorant E, van Den Brandt PA. The impact of characteristics of cigarette smoking on urinary tract cancer risk: a meta-analysis of epidemiologic studies. Cancer 2000; 89:630-639. (Pubitemid 30640110)
74. Kogevinas M, t'Mannetje A, Cordier S, et al. Occupation and bladder cancer among men in Western Europe. Cancer Causes Control 2003; 14:907-914. (Pubitemid 38091211)
75. Zavon MR, Hoegg U, Bingham E. Benzidine exposure as a cause of bladder tumors. Arch Environ Health 1973; 27:1-7.
76. Rothman N, Bhatnagar VK, Hayes RB, et al. The impact of interindividual variation in NAT2 activity on benzidine urinary metabolites and urothelial DNA adducts in exposed workers. Proc Natl Acad Sci USA 1996; 93:5084-5089. (Pubitemid 26162874)
77. Braver DJ, Modan M, Chê trit A, et al. Drinking, micturition habits, and urine concentration as potential risk factors in urinary bladder cancer. J Natl Cancer Inst 1987; 78:437-440. (Pubitemid 17036755)
78. Kunze E, Chang-Claude J, Frentzel-Beyme R. Life style and occupational risk factors for bladder cancer in Germany. A case-control study. Cancer 1992; 69:1776-1790.
79. Steinmaus CM, Nunez S, Smith AH. Diet and bladder cancer: a meta-analysis of six dietary variables. Am J Epidemiol 2000; 151:693-702. (Pubitemid 30463591)
80. Ros MM, Bas Bueno-de-Mesquita HB, Bü chner FL, et al. Fluid intake and the risk of urothelial cell carcinomas in the European Prospective Investigation into Cancer and Nutrition (EPIC). Int J Cancer 2011; 128:2695-2708.
81. VillanuevaCM, Cantor KP, King WD, et al. Total and specific fluid consumption as determinants of bladder cancer risk. Int J Cancer 2006; 118:2040-2047.
82. Valtin H. Drink at least eight glasses of water a day.' Really? Is there scientific evidence for '8 x 8'? Am J Physiol Regul Integr Comp Physiol 2002; 283:R993-R1004. (Pubitemid 35216971)
83. Negoianu D, Goldfarb S. Just add water. J Am Soc Nephrol 2008; 19:1041-1043.
84. Centre de recherche pour l'é tude et l'observation des conditions de vie (CRÉ DOC). Enquê te Comportement et Consommations Alimentaires en France (CCAF). Paris, France; 2007.
85. Vergne S. Methodological aspects of fluid intake records and surveys. Nutr Today 2012; 47:S7-S10.
86. Shirreffs SM. Global patterns of water intake: how intake data affect recommendations. Nutr Rev 2012; 70:S98-S100.
87. Gibson RS. Principles of nutritional assessment. 2nd ed New York: Oxford University Press; 2005.
88. Ma G, Zhang Q, Liu A, et al. Fluid intake of adults in four Chinese cities. Nutr Rev 2012; 70 (S2):S105-S110.
89. Manz F, Wentz A. Hydration status in the United States and Germany. Nutr Rev 2005; 63:S55-S62. (Pubitemid 40840406)
90. Henderson L, Gregory J, Swan G. The national diet and Nutrition survey: adults aged 19 to 64 years, Vol 1. Newport, UK: Office for National Statistics; 2001.
91. Gandy J. First findings of the United Kingdom Fluid Intake Study. Nutrition Today 2012; 47:S14-S16.